DOKTER BENJAMIN LEENKNEGT

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of DOKTER BENJAMIN LEENKNEGT is 2.4% (moderate). The 2025 annual accounts show equity of €2k and a net result of €496k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-12-2025, 120 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 4 filed financial years, each closing on 30-09. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-09-2025, that is 30-04-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
30-09-2025	30-04-2026	31-12-2025	120 d early	2025-00593057
30-09-2024	30-04-2025	30-12-2024	121 d early	2024-00626801
30-09-2023	30-04-2024	05-04-2024	25 d early	2024-00057852
30-09-2022	30-04-2023	28-04-2023	2 d early	2023-00070647

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

2.4% Moderate

0%0,5%1,5%4%10%≥25%

Young company +No NACE activity registered +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€496k-17.5%

Working capital€276-100.0%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 31-12-2025 with the NBB · fiscal year 2025 · verkort

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

volatile Too volatile to project: the yearly deviation from the trend is ~77% of the level (threshold 35%). We therefore deliberately show no projection line.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

EBITDA

€642k

-19.4% 22-25

Net profit

€496k

-17.5% 22-25

Cash flow

€497k

-17.5% 22-25

Total assets

€505k

-54.9% 22-25

Equity

€2k

-99.8% 22-25

Working capital

€276

-100.0% 22-25

Income taxes

€161k

-17.7% 22-25

Dividends

€1.54M

+3755.7% 22-25

Show 9 other metrics

Debt

€503k

+602.9% 22-25

Debt ≤ 1y

€503k

+602.9% 22-25

Current ratio

1.00

-93.6% 22-25

Quick ratio

1.00

-93.6% 22-25

Solvency

0.4%

-99.6% 22-25

Debt / equity

251.50

+368335.9% 22-25

ROE

24796.6%

+43141.5% 22-25

ROA

98.2%

+82.9% 22-25

Interest coverage

2216.05

-64.8% 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	verkort
Revenue	-
EBITDA	€642k
Net profit	€496k
Cash flow	€497k
Staff costs	-
Income taxes	€161k
Dividends	€1.54M
Total assets	€505k
Equity	€2k
Debt	€503k
of which ≤ 1y	€503k
of which > 1y	-
Working capital	€276
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	1.00
Quick ratio	1.00
Working capital ratio	0.1%
Solvency	0.4%
Debt / equity	251.50
Long-term debt ratio	-
Interest coverage	2216.05
Gross margin	-
Net margin	-
ROA	98.2%
ROE	24796.6%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €2k · 0.3% Current assets €503k · 99.7%

Equity & liabilities

Equity €2k · 0.4% Debt €503k · 99.6%

Full annual accounts (21 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€505k
Fixed assets	21/28	€2k
Tangible fixed assets	22/27	€1k
Financial fixed assets	28	€400
Current assets	29/58	€503k
Amounts receivable within one year	40/41	€19k
Cash & bank	54/58	€262k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€505k
Equity	10/15	€2k
Contributions / capital	10/11	€2k
Amounts payable	17/49	€503k
Amounts payable within one year	42/48	€503k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€643k
Operating result	9901	€642k
Financial income	75	€15k
Financial charges	65	€290
Result before taxes	9903	€656k
Income taxes	67/77	€161k
Net result for the period	9904	€496k
Result to be appropriated	9905	€496k

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

65 / 100 Healthy

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Ingelandgat 319000 Gent

Establishment units

1 location

Dokter Benjamin Leenknegt

Ingelandgat 31, 9000 GentActiviteiten van medisch specialisten

since 20222.326.321.801

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area125 m²

Buildings1

Building footprint103 m²

Volume (LiDAR)1,509 m³

Tallest building16.3 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
44815F1220/00D000 ProtectedMonumentHerenhuis met binnenplaatsSource ↗	Flanders	125 m²	1 · 103 m²	16.3 m · 5 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts

Address history · 1

19-05-2023

Registered-office move

All acts · 1 updated 3 years ago

2023

19-05-2023 Registered office moved within Gent Registered-office change

Hendrik Waelputstraat 2B bus 102, 9000 Gent → Ingelandgat 31 bus 101, 9000 Gent

Original publication ↗

Analysis

Financial profile

5 of 5 axes measured

66 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 65

Profitability 100

Solvency 11

Growth 58

Stability 94

Credit advice

verdict per customer and amount

Company registry

Company registry (CBE)

Crossroads Bank

Names & trade names

Legal nameNL

DOKTER BENJAMIN LEENKNEGT

Registered office

Ingelandgat 31 bus 101

9000 Gent, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.